Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 10/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 10/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 9/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 9/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 9/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10958978 | 0.72 | GAA (0.39) | GAAPOLBMAPTTDP1KMT2A | |
| SCHEMBL10955537 | 0.71 | ALDH1A1 (0.42) | GAAPOLBMAPTTDP1KMT2A | |
| SCHEMBL22198801 | 0.70 | CYP2E1 (0.50) | CYP2E1CYP3A4CYP2D6CYP2A6CYP2C9 | |
| SCHEMBL10898596 | 0.70 | GAA (0.51) | GAAPOLBMAPTTDP1KMT2A | |
| SCHEMBL3258927 | 0.70 | POLB (0.48) | GAAPOLBMAPTTDP1KMT2A | |
| SCHEMBL28941639 | 0.69 | ALDH1A1 (0.39) | GAAPOLBMAPTTDP1KMT2A | |
| SCHEMBL21402172 | 0.69 | — | — | |
| SCHEMBL8646945 | 0.67 | BRD4 (0.43) | GAAPOLBMAPTTDP1KMT2A | |
| SCHEMBL9534606 | 0.67 | ALDH1A1 (0.46) | GAAPOLBMAPTTDP1KMT2A | |
| SCHEMBL6940138 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3386935-B1 | PRODUCTION OF XYLENE DERIVATIVES | RHODIA OPERATIONS (FR) | 2021-12-01 | — | — | EP | disclosed |
| WO-2021114207-A1 | PRODUCTION OF BENZENE DERIVATIVES | RHODIA OPERATIONS (FR) | 2021-06-17 | — | — | WO | disclosed |
| US-10815245-B2 | Production of xylene derivatives | RHODIA OPERATIONS (FR) | 2020-10-27 | — | — | US | disclosed |
| US-10100145-B1 | Amorphous polyester from bio-based bis-furan assembly | THE UNIVERSITY OF TOLEDO (US) | 2018-10-16 | — | — | US | disclosed |
| WO-2017097220-A1 | PRODUCTION OF XYLENE DERIVATIVES | RHODIA OPERATIONS (FR) | 2017-06-15 | — | — | WO | disclosed |
| WO-2017096559-A1 | PRODUCTION OF XYLENE DERIVATIVES | RHODIA OPERATIONS (FR) | 2017-06-15 | — | — | WO | disclosed |
| US-9527952-B1 | Amorphous polyester from bio-based bis-furan assembly | THE UNIVERSITY OF TOLEDO (US) | 2016-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10815245-B2 | Production of xylene derivatives | DCXR, XDH, HPD | GAA 3188/4885POLB 2367/4885MAPT 1516/4885 |
| US-10100145-B1 | Amorphous polyester from bio-based bis-furan assembly | FASN, PGD, ACMSD | GAA 1839/4885POLB 2967/4885MAPT 1699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.